Avadel Pharmaceuticals Plc (AVDL) Directors and Executive Officers - CSIMarket
CSIMarket
 
Avadel Pharmaceuticals Plc  (NASDAQ: AVDL)

Avadel Pharmaceuticals Plc

Officers & Directors


Dr. Eric J. Ende
Director

Geoffrey M. Glass
Non-Executive Chairman of the Board and Director

Peter J. Thornton
Director

Mark A. McCamish, MD, Ph.D.
Director

Thomas S. McHugh
Chief Financial Officer and Principal Financial and Accounting Officer

Gregory J. Divis
Director, Chief Executive Officer and Principal Executive Officer

Linda S. Palczuk
Director ,

Avadel Pharmaceuticals Plc currently has 154 employees.

  News about Avadel Pharmaceuticals Plc Key Personnel

Avadel Pharmaceuticals Seeks Revival Amid Financial Struggles: New VP of Sales and Inducement Awards Signal Shift in Strategy

Avadel Pharmaceuticals Seeks Revival Amid Financial Struggles: New VP of Sales and Inducement Awards Signal Shift in Strategy DUBLIN, Feb. 24, 2025 – In a swift response to financial pressures, Avadel Pharmaceuticals plc (Nasdaq: AVDL) has announced the appointment of Kevin Springman as Vice President of Sales, aiming to revitalize its commercial strategy amidst a backdrop of significant net losses and underwhelming return on assets (ROA).Previously, Avadel recorded a staggering cumulative net loss of $80 million over the past year, leading to an alarming -46.63% ROA and placing the company at a disadvantage among its peers in the healthcare sector. While 562 healthcare companies demonstrated stronger fin...






AVDL Management Effectiveness AVDL Revenue per Employee AVDL Income per Employee


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.